Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a minor platform release. No changes appear to affect study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-01T19:57:13.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The changes add funding context (NIH grant/contract), explicitly reference Multiple Myeloma in related topics, and include a MedlinePlus Genetics related topics link, providing extra background information without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-25T21:43:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page no longer displays the disease name 'Multiple myeloma' and the 'MedlinePlus Genetics' related topics section. This removes explicit disease context and a related informational link from the Study Details page.
    Difference
    0.1%
    Check dated 2026-08-18T20:01:57.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now includes Data sharing and IPD Plan sections detailing data-access policies and related documents, and the previous revision tag 'Revision: v3.6.4' was removed.
    Difference
    100%
    Check dated 2026-08-11T17:50:30.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Deleted entries in the Study Documents section that provided access to major trial documents (Statistical Analysis Plan, Study Protocol) and the data-sharing/IPD information, reducing availability of key methodological and transparency resources for the DREAMM-3 trial.
    Difference
    16%
    Check dated 2026-08-04T16:07:55.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4. This indicates a minor update/patch to the page’s metadata.
    Difference
    0.0%
    Check dated 2026-07-21T13:23:07.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.